SCHEMBL5162210

SCHEMBL5162210

C=CB(O)c1cccc(Cl)c1N(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DOT1L Q8TEK3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833079 0.76 ALDH1A1 (0.41)
SCHEMBL16746561 0.71 CYP1A2 (0.43) DOT1L
SCHEMBL3787606 0.64 MAPT (0.44) DOT1L
SCHEMBL21395985 0.64 ESR1 (0.40) DOT1L
SCHEMBL28963581 0.64 THRB (0.42)
SCHEMBL3841471 0.63
SCHEMBL1138696 0.63 TTR (0.36)
SCHEMBL24747465 0.63 ALDH1A1 (0.38)
SCHEMBL2103990 0.63 POLB (0.35) DOT1L
SCHEMBL21027096 0.62 CYP1A2 (0.35) DOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765359-A2 ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE Anacor Pharmaceuticals, Inc. (US) 2007-03-28 EP disclosed
WO-2006007384-A2 ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE ANACOR PHARMACEUTICALS, INC. (US) 2006-01-19 WO disclosed